Study of Pitavastatin Vs. Atorvastatin (Following Up-Titration) in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia.

Trial Profile

Study of Pitavastatin Vs. Atorvastatin (Following Up-Titration) in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Nov 2012

At a glance

  • Drugs Pitavastatin (Primary) ; Atorvastatin
  • Indications Dyslipidaemias
  • Focus Registrational; Therapeutic Use
  • Sponsors Kowa Pharmaceutical
  • Most Recent Events

    • 08 Nov 2012 Planned number of patients changed from 300 to 400.
    • 08 Nov 2012 Planned number of patients changed from 300 to 400.
    • 01 Nov 2011 Results for parent trial published in the Diabetes, Obesity and Metabolism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top